Windtree Therapeutics Inc (OTCQB:WINT)

3.85
Delayed Data
As of May 24
 +0.10 / +2.67%
Today’s Change
2.28
Today|||52-Week Range
20.00
-8.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues2.8M987.0K2.0M1.5M
 
 
 
 
 
Cost of Goods Sold2.7M693.0K0.00--
 
 
 
Depreciation And Amortization818.0K712.0K255.0K192.0K
 
 
 
 
 
 
Operating ExpensesGross Income-654.0K-418.0K1.8M--
 
 
 
 
General Expenses42.6M37.5M38.2M23.8M
 
 
 
 
 
Research And Development25.9M27.4M31.5M17.2M
 
 
 
 
 
Total Operating Expenses46.1M38.9M38.5M24.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-43.3M-37.9M-36.4M-22.5M
 
 
 
 
 
Extraordinary Credit3.8M851.0K223.0K5.8M
 
 
 
 
 
Extraordinary Charge---13.7M-1.6M--
 
 
 
Interest Expense On Debt4.6M4.6M2.5M1.9M
 
 
 
 
 
Other Expenses0.00150.0K823.0K129.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.1M-55.2M-39.5M-18.4M
 
 
 
 
 
Preferred Dividend0.000.000.00-6.4M
 
 
Net Income-44.1M-55.2M-39.5M-18.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS303.9K348.3K416.4K1.0M
 
 
 
 
 
Shares To Calculate EPS Diluted307.2K348.3K416.4K1.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$156.80-$2,234.40-$94.80-$24.14
 
 
 
 
 
EPS Diluted-$145.60-$158.38-$95.37-$24.14